A Study Comparing the Differences Between Young and Non-young Breast Cancer

NCT ID: NCT06793306

Last Updated: 2025-02-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

3000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-01-01

Study Completion Date

2030-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To collect data on diagnosis, treatment, survival prognosis, and intrinsic molecular detection of breast cancer in China from January 2000 to December 2024.Compare the difference between young and non-young breast cancer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Breast cancer

Age

Intervention Type OTHER

Breast cancer patients were divided into young breast cancer and non-young breast cancer by age 35

combination therapy

Intervention Type OTHER

To observe and compare the difference in diagnosis, combined treatment and prognosis between young and non-young breast cancer

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Age

Breast cancer patients were divided into young breast cancer and non-young breast cancer by age 35

Intervention Type OTHER

combination therapy

To observe and compare the difference in diagnosis, combined treatment and prognosis between young and non-young breast cancer

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* During the period from January 2000 to December 2024, the first breast cancer diagnosed and treated in several hospitals in China was in the age range of 18-75 years.

Exclusion Criteria

* Breast cancer patients under 18 years of age or over 75 years of age; Combined with other malignant tumors; Patients with chronic infectious diseases or chronic infectious diseases; Patients with severe comorbidities, with serious dysfunction of vital organs (heart, liver, kidney); Known history of human immunodeficiency virus; The investigator concluded that patients should not be included in other conditions of this trial.
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

PENG YUAN

Head of department

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cancer Hospital, Chinese Academy of Medical Sciences

Beijing, , China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NCC5093

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Familial Breast Cancer in China
NCT06833216 NOT_YET_RECRUITING
Hong Kong Breast Cancer Study
NCT02889458 ACTIVE_NOT_RECRUITING